Company intelligence / Profile preview

Centristic

Rotterdam, Zuid Holland, Netherlandscentristic.co.uk ↗

Ownership: Private
Employees: ~1800
Development stage: Commercial

Overview

Centrient Pharmaceuticals is a global leader in the sustainable manufacture of antibiotics, next-generation statins, and antifungals using both chemical synthesis and enzymatic processes. The company supplies intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms to business customers worldwide[1][3][4].

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small moleculeEnzymatic antibiotic (Biologic/Enzyme-based manufacturing process for small molecules)
Industry: Contract Manufacturing Organization

Partnerships

Ginkgo Bioworks – partnership to expand sustainable innovation in generic API space[5]

Beyond the preview

Go deeper on Centristic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centristic.

Explore the full profile